Clinical Trial Update: A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

This document reports the completed Phase 3 long-term study of DE-114 Ophthalmic Solution for allergic conjunctivitis, with results posted in 2014. Sponsor: San…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• DE-114 Ophthalmic Solution

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-23